Integrative Identification of Epstein–Barr Virus–Associated Mutations and Epigenetic Alterations in Gastric Cancer-Reference-Cited by-同舟云学术

Integrative Identification of Epstein–Barr Virus–Associated Mutations and Epigenetic Alterations in Gastric Cancer

Published:2014-12 Issue:6 Volume:147 Page:1350-1362.e4
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Liang Qiaoyi,Yao Xiaotian,Tang Senwei,Zhang Jingwan,Yau Tung On,Li Xiaoxing,Tang Ceen-Ming,Kang Wei,Lung Raymond W.M.,Li Jing Woei,Chan Ting Fung,Xing Rui,Lu Youyong,Lo Kwok Wai,Wong Nathalie,To Ka Fai,Yu Chang,Chan Francis K.L.,Sung Joseph J.Y.,Yu Jun

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference50 articles.

1. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer;Zhao;Cancer,2012

2. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma;Fukayama;Cancer Sci,2008

3. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells;Zhao;Cancer,2013

4. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma;Hino;Cancer Res,2009

5. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer;Wang;Nat Genet,2011

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High infiltration of immune cells with lower immune activity mediated the heterogeneity of gastric adenocarcinoma and promoted metastasis;Heliyon;2024-09

2. Development and validation of a risk prognostic model based on the H. pylori infection phenotype for stomach adenocarcinoma;Heliyon;2024-09

3. Stomach microbiota in gastric cancer development and clinical implications;Gut;2024-06-17

4. Color morphing surfaces with effective chemical shielding;Nature Communications;2024-05-03

5. Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers;Nature Communications;2024-05-03